Arkolith/Insider Trading/AEON/Form 4

Wilson Alexander Blair

CLO and Corporate SecretaryAEON Biopharma, Inc. (AEON) · full profile →Form 4 · filed Jul 24, 2023
No Open-Market Flow
Open-Market Buys
$0
Open-Market Sells
$0
Net Open-Market Flow
$0
Transactions
4
0 non-derivative · 4 derivative

Derivative Transactions (Table II)

DateActionSharesPriceValueOwned After
Jul 21, 2023Grant(A)81K—$081K
Jul 21, 2023Grant(A)78K—$078K
Jul 21, 2023Grant(A)13K—$013K
Jul 21, 2023Grant(A)107K—$0107K

Transaction Codes

A
Grant / award

Data Source & Provenance

Parsed from a single SEC EDGAR Form 4 filing (accession 0001104659-23-083570) within minutes of acceptance. Every field above traces to the original document. Verify it directly:

View original filing on SEC.govRaw Form 4 XML